CFAR Scientific Symposium

2018 CFAR Scientific Symposium: Opioids and HIV

Opioids and HIV

The purpose of this meeting is to update the San Francisco Bay Area (HIV research) community on the opioid epidemic and the current state of the science, especially as it pertains to HIV. We envision a broad scope covering national epidemiology and trends, an overview of the drug market (heroin versus fentanyl, an overview of clinical interventions available, a panel discussions on innovative uses of buprenorphine and safe consumption spaces, current research and interventions happening at the Veterans Affairs Medical Center, and policy and social justice developments.


Understanding Changes in the U.S. 'Heroin' Market: Notes from the Field

The Evolving Epidemiology of HIV Infection in Persons Who Inject Drugs: Lessons Learned from Indiana 2015

Conditions of Possibility: Harm Reduction as a Pathway to Healing the Harms Caused by Racialized Drug Policies

Panel Discussion: Safe Consumption Spaces

Clinical Interventions to Address the Opioid-Infectious Disease Syndemic

Panel Discussion: Out of the Box Care for Persons Who Use Drugs

Moving Beyond MEDD and Opioids to Address the Opioid Crisis

Unintended Consequences of the Opioid Epidemic on Clinician Practice

Phillip Coffin, MD, MIA
Director, Center on Substance Use and Health, San Francisco Department of Public Health
Planning Committee
César Cadabes
Community Engagement and Communications Program Analyst